A Sod1 G93A mouse model of ALS had elevated levels of Atf6f compared to wild-type mice at early symptomatic and end stages of disease, suggesting that Atf6 could play an important role in progression of ALS and other neurodegenerative conditions (Kikuchi et al., 2006). This evidence concerns the gene ATF6 and amyotrophic lateral sclerosis.